Penta lysine
Penta lysine is an antimicrobial peptide. Penta lysine inhibits the growth of Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus and Bacillus subtilis) as well as Gram-negative bacteria (including Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa). Penta lysine induces hemolysis in human red blood cells. Penta lysine can be used in the research of bacterial infections (including MRSA and Pseudomonas aeruginosa infections).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 19431-21-1
- Formel: C30H62N10O6
- Molecular Weight:658.88
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
Penta lysine (LLLLL) (0.0625-128 μg/mL; 16 h) inhibits growth of E. coli, A. baumannii, P. aeruginosa, S. aureus, MRSA, and B. subtilis with MIC values ranging from 2.3 μM (MRSA) to 36 μM (A. baumannii)[1].
Penta lysine (142 μM) induces 6.9% hemolysis of human red blood cells at 142 μM[1].
Penta lysine has an apparent lipophilicity corresponding to a retention time of 19.1 min on a reversed-phase C18 HPLC column[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 19431-21-1
-
Molecular Weight 658.88
-
Formel C30H62N10O6
-
Sequence
Lys-Lys-Lys-Lys-Lys
-
Sequence Shortening
KKKKK
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)